The overall objective of this proposal is to understand the molecular and biochemical basis underlying the regulation of the p53 tumor suppressor protein in mammalian systems. Our approach is to focus on a specific cellular process that modifies the properties of the p53 protein and thus its functions in response to DNA damage caused by UV radiation or cisplatin treatment. Hence, utilizing p53 as a probe, we have identified and purified a stress-responsive kinase complex that specifically targets serine 392 which is evolutionarily conserved and plays a critical role in regulating p53 activity. This newly identified kinase complex contains chromatin-related transcriptional elongation factor FACTp140/SSRP1 and the alpha, alpha' and beta subunits of casein kinase II (CKII). Molecular delineation of its role in regulating p53 function will shed light on the mechanisms of DNA damage-induced p53 signaling.
Three specific aims are to dissect the mechanisms of p53 regulation by this kinase in response to DNA damage in experimental and biological contexts. 1) To determine how the substrate selectivity of the FACTp140/SSRP1-associated p53 kinase complex is achieved. Using the C-terminal domain of p53 as a substrate, the serine 392 kinase will be purified and characterized from UV- or cisplatin-treated HeLa cell nuclear extracts using conventional chromatography and affinity columns. Kinetic analysis of this kinase will be performed to examine the biochemical mechanism of its substrate specificity. Molecular, biochemical and cell biological methods will be developed to determine protein-protein interactions among the components of the complex and their association with p53 in vitro and in vivo. Interacting domains will be mapped, and the effect of deletion mutants of these kinase components on the substrate selectivity will be assessed. 2) To determine the mechanism by which the FACTp140-SSRP1-associated p53 kinase is activated in response to DNA damage. The activation of this kinase in cells after DNA damage or transcriptional attenuation will be analyzed. Co- localization of the p53 S392 kinase components after DNA damage and the effect of cisplatin-damaged DNA on the assembly and activity of this kinase complex in vitro will be analyzed. The effects of dominant negative mutants of FACTp140 or of SSRP1 on the p53 S392 phosphorylation will be assessed after DNA damage. 3) To determine whether the FACTp140-SSRP1-associated p53 kinase regulates p53 stability and activity after DNA damage. The effects of this kinase on MDM2-mediated p53 ubiquitination in vitro and in vivo, p53 stability and transcriptional activity- will be evaluated in various cells after DNA damage. These studies will systematically elucidate the novel multi- subunit protein kinase complex and will also contribute to a better understanding of a different p53 regulation mechanism in response to DNA damage. This investigation has important implications for anti-cancer drug development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA093614-02
Application #
6620642
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Pelroy, Richard
Project Start
2002-01-10
Project End
2006-12-31
Budget Start
2003-01-01
Budget End
2003-12-31
Support Year
2
Fiscal Year
2003
Total Cost
$287,013
Indirect Cost
Name
Oregon Health and Science University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Zhang, Qi; Zeng, Shelya X; Lu, Hua (2015) Determination of Maximum Tolerated Dose and Toxicity of Inauhzin in Mice. Toxicol Rep 2:546-554
Dai, Mu-Shui; Challagundla, Kishore B; Sun, Xiao-Xin et al. (2012) Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF. J Biol Chem 287:17120-9
Dai, Mu-Shui; Sun, Xiao-Xin; Lu, Hua (2010) Ribosomal protein L11 associates with c-Myc at 5 S rRNA and tRNA genes and regulates their expression. J Biol Chem 285:12587-94
Zeng, Shelya X; Li, Yanping; Jin, Yetao et al. (2010) Structure-specific recognition protein 1 facilitates microtubule growth and bundling required for mitosis. Mol Cell Biol 30:935-47
Kumari, Anuradha; Mazina, Olga M; Shinde, Ujwal et al. (2009) A role for SSRP1 in recombination-mediated DNA damage response. J Cell Biochem 108:508-18
Dai, Mu-Shui; Lu, Hua (2008) Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J Cell Biochem 105:670-7
Dai, Mu-Shui; Sun, Xiao-Xin; Lu, Hua (2008) Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol Cell Biol 28:4365-76
MacPartlin, Mary; Zeng, Shelya X; Lu, Hua (2008) Phosphorylation and stabilization of TAp63gamma by IkappaB kinase-beta. J Biol Chem 283:15754-61
Jin, Yetao; Zeng, Shelya X; Sun, Xiao-Xin et al. (2008) MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2. Mol Cell Biol 28:1218-29
Gallegos, Jayme R; Litersky, Joel; Lee, Hunjoo et al. (2008) SCF TrCP1 activates and ubiquitylates TAp63gamma. J Biol Chem 283:66-75

Showing the most recent 10 out of 29 publications